Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.190
-0.130 (-3.92%)
Oct 29, 2025, 4:00 PM EDT - Market closed
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $1.86 million as of October 29, 2025. Its market cap has increased by 15.48% in one year.
Market Cap
1.86M
Enterprise Value
-4.20M
1-Year Change
15.48%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $1.86M, a decrease of -99.42%. That is a compound annual growth rate of -73.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 1.94M | -79.27% |
| Dec 31, 2024 | 9.34M | -88.50% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
| Dec 10, 2021 | 323.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.04B |
| Johnson & Johnson | 457.77B |
| AbbVie | 402.76B |
| UnitedHealth Group | 328.31B |
| AstraZeneca | 258.55B |
| Novartis AG | 253.40B |
| Novo Nordisk | 236.76B |
| Abbott Laboratories | 220.78B |